|
Latest update 28/03/10
This chapter is set out as follows:
Erythrodermic psoriasis is discussed in the section on erythroderma
Introduction
Definition
Psoriasis is a common, genetically determined, inflammatory and proliferative disorder of the skin, the most characteristic lesions consisting of chronic, sharply demarcated, dull-red, scaly plaques, particularly on the extensor prominence and in the scalp. Morphological variants are common
Incidence and prevalence
- Affects around 3% of the population
- It is uncommon in certain populations such as oriental people, native American Indians and West Africans
- Both sexes are equally affected
- It may develop at any age although it most frequently presents in young adults and in the sixth & seventh decades
Pathophysiology
- Recent research suggests that psoriasis is an autoimmune disease
- Abnormally large numbers of T cells trigger the release of cytokines in the skin causing the inflammation, redness, itching and flaky skin patches characteristic of psoriasis
Aetiology
- Genetic factors are important, especially in the younger age group (a family history is present in 40-50% and up to 75% if onset is before age 20)
- High concordance in monozygotic twins and lesser (15-20%) in dizygotic twins
- Lifetime risk - 4% if no family history, 28% if one parent affected, 65% if both parents affected
Triggers
- Trauma – psoriasis at the site of injury (Köbner phenomenon)
- Infection – streptococcal infection, especially of the throat is well known to provoke guttate psoriasis. Continuing subclinical infection may also play a role in refractory chronic plaque psoriasis
- Pregnancy – if psoriasis alters it is more likely to improve in pregnancy but get worse postpartum
- Sunlight – although sunlight is generally beneficial, a small minority have symptoms provoked by strong sunlight
- Drugs – a wide range of drug are said to affect psoriasis. The most notable associations include lithium, beta-blockers, anti-malarials and NSAIDs
- Stress – may worsen symptoms
- Alcohol – heavy drinking is more common in patients with psoriasis. It is hard to know if excessive alcohol has a direct effect on psoriasis but the reduced compliance with treatment is likely to exacerbate symptoms
- Smoking – is a risk for both palmoplantar pustulosis and chronic plaque psoriasis
- HIV – exacerbates psoriasis
Psoriatic arthropathy
Recent studies suggest that the prevalance of psoriatic arthritis in patients with psoriasis may be up to 30%. There is a strong link with nail disease
Psoriatic arthritis has been divided into five subtypes:
- Distal interphalangeal
- Symmetric polyarthritis (resembles RA)
- Asymmetric oligoarthritis – large joint
- Spondylitis
- Arthritis mutilans – a severe destructive form affecting fingers and toes
It is worth asking all psoriatic patients about joint symtoms, and then acting on those that appear to be inflammatory in nature. Differentiating between rheumatoid artiritis (RA) and psoriatic arthritis (PA) can be difficult however a new blood test for anti-CCP (anti-cyclic citrullinated peptide antibody) is much more specific for RA than older tests. All patients with an inflammatory arthropathy, whether RA or PA should receive prompt treatment as this may help reduce long-term complications. Such patients are often best managed in a combined approach with the rheumatologists
Chronic plaque psoriasis
Key diagnostic features
- Itch – patients can experience itch, although it is usually much less marked than with eczema
- Distribution:
- Symmetrical
- Extensor surfaces
- Can be widespread
- Morphology:
- Ruby-red, well-defined plaques
- Silvery surface scale
- Auspitz’s sign - when adherent psoriatic scales are scraped or picked off, pinpoint bleeding known as Auspitz's sign may occur. The pinpoint areas represent the tops of tiny capillaries which undulate vertically throughout the thickened psoriatic skin
- Lesions on lower legs may be less typical
- Other affected sites: see below
 |
Figure 1 - Common sites for psoriasis |
 |
Figure 2 – Chronic plaque psoriasis
Well-defined deep-red plaques with surface scale
|
 |
Figure 3 – Chronic plaque psoriasis of the knees
|
 |
Figure 4 - Chronic pla que psoriasis of the upper back |
 |
Figure 5 - Small plaque psoriasis |
 |
Figure 6 - Close up of figure 5 |
 |
Figure 7 - Psoriasis
The differential diagnosis could include Pityriasis versicolor |
 |
Figure 8 - Psoriasis. Close up of figure 7
Closer examination clarifies the diagnosis |
 |
Figure 9 - Auspitz sign
Arrow denotes small haemorrhage that is seen following removal of scale
(copied with kind permission of Danderm)
|
 |
Figure 10 - Psoriasis on lower legs |
 |
Figure 11 – Thin plaques of psoriasis on the lower legs
Suitable for treatment with a topical tar preparation
|
 |
Figure 12 – Psoriasis with large plaque right forearm
|
 |
Figure 13 – Psoriasis of the gluteal cleft
|
 |
Figure 14 – Psoriasis affecting the concha of the ear
|
 |
Figure 15 – Psoriasis affecting the umbilicus
|
 |
Figure 16 – Cutaneous T-cell lymphoma (CTCL)
CTCL is one of the great mimickers of skin disease. Although it can present in many ways, lesions tend to start off flat and respond poorly to topical treatments. Over a number of years lesions become plaque-like and start to ulcerate. A biopsy of early CTCL may miss the diagnosis – unusual rashes are best referred to a specialist
|
Management of chronic plaque psoriasis
General points
As with other chronic skin conditions
- Time is needed by the GP / practice nurse to discuss the condition
- Provide patient information leaflets and direct to appropriate websites
- Advise on a pre-payment exemption certificate where appropriate
- Prescribe copious emollients – these make the skin more comfortable and reduce the amount of scale
- The active treatments below should be used for psoriasis flare-ups until the plaques are controlled, with a treatment holiday between flares when the use of regular emollients should be still be encouraged
Step I - Topical agents
- Dovobet ® is the most effective vitamin D analogue and should be considered as first line for the majority of patients. It is best avoided on areas of thin skin e.g. the face, flexures and the genitalia (see later). Appropriate quantities (i.e. 120g) should be prescribed. It comes in two formulations:
- Dovobet ® gel used OD - patients often prefer gels to ointments / the gel can also be used on scalp psoriasis
- Dovobet ® ointment used OD - some patients may find this more effective than the gel
- Large thin plaques - it is preferable to use tar preparations e.g. Exorex ® lotion or Alphosyl HC ® cream (avoid the latter in egg allergy)
- Other treatments options include
- Zorac ® gel 0.05% or 0.1% OD - can cause significant irritation and so may need to use a topical steroid at the other end of the day to reduce irritation
- Dithranol preparations, such as the short contact dithranol regime remain the most effective topical treatments but patient acceptability limits their use
- In patients presenting with lesions that have thick scale it may be necessary to use de-scaling agents prior to commencing t he treatments referred to above. One such treatment is 5% salicylic acid in yellow soft paraffin applied BD – this can be very expensive if dispensed in the community, and there is often substantial variations in cost across different pharmacies
Step 2 - Second line treatments
Patients with moderate-severe psoriasis at the onset, and those who fail to respond adequately to topical treatments such be referred for consideration of second line treatment, which include:
- Light therapy – most patients receive narrow band UVB known as TL01 therapy. UVA therapy by way of PUVA is sometimes used. Their is a maximum dose of light therapy that a patient may receive in a life time to limit the risks of skin cancer
- Ciclosporin – acts quickly. It is an immunosuppressive agent and so is best used in younger patients who have not already received light therapy. The main risks are of hypertension and renal damage, which limit how long the treatment can be given for. It can be used in three-monthly pulses to extend its use
- Methotrexate – is still one of the most effective treatments and it can also help some patients with psoriatic arthropathy. The main risks are liver damage, and bone marrow suppression which can occur in the early stages of treatment - patients should be advised to report immediately for a FBC if they have a sore throat or other signs of infection. Methotrexate cannot be used in pregnancy
- Acitretin – is one of the mildest but safest treatments. It can be particularly useful in hyperkeratotic hand / foot psoriasis. Acitretin is highly teratogenic and pregnancy needs to be avoided while on acitretin and for two years after, for this reason it is generally avoided in women of child bearing age
- Others drugs include the Fumarates and hydroxyurea
Step 3 – The biologics
- The biologics are the newest treatment for psoriasis and can benefit patients with psoriasis and psoriatic arthropathy. They work by interfering with specific components of the autoimmune response. Unlike general immunosuppressants that suppress the entire immune system, biologics fight more selectively and target only those chemicals involved in causing psoriasis
- Etanercept, infliximab and adalimumab belong to the class of biological medicines called tumour necrosis factor (TNF) blockers. These work by blocking the activity of TNF, the primary cytokine involved in psoriasis. Alefacept is a T-cell blockers and block the overactive T-cells
- While the biologics are effective for many patients with psoriasis their long-term effects are as ye t unknown and so they are used only in accordance with NICE guidelines, which often means that the second line treatments referred to above have already been tried but have either been ineffective or not tolerated
Guttate psoriasis
Clinical features
- Typically triggered 7-10 days after a streptococcal URTI
- It is a common pattern in children and young adults
- Distribution – even distribution over the body, especially on the trunk and proximal limbs. Relative sparing of the face
- Morphology – small, round-oval scaly lesions up to 1cm in diameter. In the early stages there may be little scale. The Köbner phenomenon may be present
Management
- In mild cases of guttate psoriasis the use of an emollient regimen may be sufficient until spontaneous clearance occurs, usually after 2-3 months. While natural sunlight in moderation can improve guttate psoriasis, the use of UV sun-beds without medical supervision is discouraged
- Topic al treatment - coal tar preparations e.g. Exorex lotion can be beneficial as they can be applied more generally to a large area of skin. Vitamin D analogues can be used but because these treatments are best applied directly to the lesions, with large numbers of lesions application is very time consuming and may not be acceptable to some patients
- Referral to dermatology for a course of narrow band UVB is an effective treatment for widespread / unresponsive cases
Prognosis
- While some will go on to develop ordinary psoriasis at a later stage, 1/3 do not have a family history and don’t go on to develop psoriasis in adulthood
 |
Figure 17 – Early guttate psoriasis with little scale
|
 |
Figure 18 – Guttate psoriasis
|
Generalised pustular psoriasis
Clinical
- Irregular red patches
- Small pustules (1-2mm)
- Systemic upset with sore skin, fever and malaise
Some cases are drug-induced and abrupt withdrawal of systemic corticosteroids or very potent topical steroids in a patient with known psoriasis is a significant risk factor
Management
- Patients are often very unwell and need admitting. The most appropriate course of action is to phone the on call dermatologist
 |
Figure 19 – Generalised pustular psoriasis
(copied with kind permission of Dermatoweb)
|
 |
Figure 20 – Generalised pustular psoriasis (close up)
|
 |
Figure 21 – Pustular psoriasis
(copied with kind permission of Dermatoweb)
|
Palmoplantar pustulosis
Incidence and aetiology
- Age - mainly presents in patients over 50
- Females > males
- Strong link with cigarette smoking (unfortunately stopping smoking does not often lead to an improvement)
- Approximately 25% have a background of chronic plaque psoriasis
Clinical
- Palms, feet (especially heel and instep) or both
- Erythematous plaques with yellow / brown pustules
Treatment
- Can be difficult
- Potent topical steroids such as 0.1% betnovate or dermovate - occulsion with clingfilm may be of benefit
- Patients failing to respond should be referred to dermatology out-patients for consideration of hand/foot phototherapy or systemic agents
 |
Figure 22 – Palmoplantar pustular psoriasis
Sterile yellow and brown pustules
|
 |
Figure 23 – Palmoplantar pustular psoriasis
|
 |
Figure 24 – Palmoplantar pustular psoriasis
(copied with kind permission of Dermatoweb)
|
Specific sites – scalp
Clinical
- Plaques of psoriasis often separated by normal areas of scalp
- Scalp margins and above the ears are frequently affected
Management
- Shampoo for long-term management
- Tar based preparations e.g. Polytar (plus) ® or Capasal ® shampoo are useful when scale is present - massage into the scalp for 5 minutes to allow shampoo to penetrate the scale and then wash out
- Some patients are not keen on the smell of tar based preparations and may wish to try an alternative such as Dermax ® shampoo
- Topical applications for flare ups
- If the shampoo alone does not suffice add in a topical application
- Dovobet ® gel should be considered first line as it has the benefit of combining a topical steroid with a vitamin D analogue, and is proven to be superior when compared to using either agent alone. It should be massaged into a dry scalp and washed out the following morning with shampoo. Dovobet gel can leave the scalp feeling greasy and so it is recommended that shampoo is massaged in to the treated areas of the scalp and left on for about 5 minutes before washing off
- There are a number of alternatives to Dovobet gel such as Betacap ® scalp application and Etrivex ® shampoo. It is best to avoid alcohol based solutions, which are not as well tolerated. Betacap needs to be left on the scalp, whereas Etivex is a shampoo that needs to be massaged on to the scalp and left on for 20 minutes before washing out
- Some pateints present with thick scale and this needs to be removed before commencing the topical applications referred to above. Sebco ® scalp ointment is very effective at removing scale - massage into affected areas of the scalp for 5 minutes and leave on for at least 2 hours, or overnight before washing out with shampoo (some patients cannot tolerate the treatment for more than a few hours). The treatment is messy and so if left on overnight patients should use an old pillowcase or towel, alternatively the scalp can be occluded with a shower cap. Sebco may be need to be used for a few days until the scale diminishes, and then used PRN as the scale builds up. Warn patients that hair loss may occur as the scale come away, but that this will recover
- For psoriasis of the hair margins - consider 1% hydrocortisone ointment / Eumovate ® ointment BD
 |
Figure 25 – Scalp psoriasis
|
 |
Figure 26 – Scalp psoriasis with hairline involvement
(copied with kind permission of Dermatoweb)
|
 |
Figure 27 – Scalp psoriasis with thick scale
Sebco ointment was needed to remove the scale before other treatments could be used
(copied with kind permission of Dermatoweb)
|
Specific sites – face
Clinical findings
- The face is not a common site for psoriasis
- Patients occasionally present with well-demarcated plaques. A more frequent finding is similar to that seen in seborrhoeic dermatitis, indeed the two can be very difficult to tell apart and as such this presentation is sometime referred to as sebo-psoriasis
Treatment
The face, along with the hands and genitalia represent important cosmetic areas and the presence of psoriasis at these sites produces disproportionate distress. Improving psoriasis at these sites is of great importance. Treatment options include:
- Emollients
- The vitamin D analogues Curatoderm ® lotion or ointment and Silkis ® ointment
- Although weaker topical steroids such as 1% hydrocortisone or Eumovate can be used, there is a risk of atrophy and so an alternative choice is 0.1% Tacrolimus ® ointment, which although off-label when used in this context can be very effective for facial psoriasis
 |
Figure 28 – Facial psoriasis
(copied with kind permission of Dermatoweb)
|
 |
Figure 29 – Sebopsoriasis
(copied with kind permission of Dermatoweb)
|
 |
Figure 30 – Facial psoriasis, treated with 0.1% proptopic ointment
Involvement around the eye is more common in children compared with adults
|
 |
Figure 31 – As above, 2 weeks later
|
Specific sites - hands and feet
Clinical findings
Psoriasis can affect the hands and feet in 3 main ways:
- As part of a general psoriasis (images 28 & 29) - manage as per chronic plaque psoriasis
- Palmoplantar pustular psoriasis - see earlier in the article
- Hyperkeratotic psoriasis (images 30 & 31)
Hyperkeratotic psoriasis – clinical findings
- In absence of other signs of psoriasis it can be difficult to differentiate from hyperkeratotic hand dermatitis (although management of the two is very similar)
- In psoriasis the plaques are usually, but not always well demarcated
- If there are any doubts about the diagnosis skin scrapings should be sent for mycology to rule out tinea
Hyperkeratotic psoriasis – management
- It often worth giving patient information leaflet on hand dermatitis – although this is not the primary diagnosis many patients will have a degree of irritant contact dermatitis and anything that can be done to make the skin more comfortable is of value
- Moisturisers and soap substitutes
- If scale is very marked (more commonly seen on the feet) this can be reduced using 5% salicylic in yellow soft paraffin twice a day - community pharmacies can send away for this to be made up (there is considerable variation in price so it is worth finding out who is most cost effective)
- For erythema and lesser degrees of scale Diprosalic ® ointment can be used OD to BD
- Using the treatments under occlusion e.g. cotton gloves for hands and clingfilm for feet can provide additional benefit
- For more patients failing to respond to treatment / or where diagnostic uncertiainty exists e.g. contact allergic dermatitis, patients should be referred to a specialist. The use of systemic treatments such as Neotigason ® (Acitretin) and Toctino ® (Alitretinoin) can lead to substantial improvement
 |
Figure 32 – Psoriasis
|
 |
Figure 33 – Psoriasis
|
 |
Figure 34 – Hyperkeratotic hand psoriasis
(copied with kind permission of Dermatoweb)
|
 |
Figure 35 – Hyperkeratotic hand psoriasis. Note the clear demarcation
(copied with kind permission of Dermatoweb)
|
 |
Figure 36 – Hyperkeratotic hand and foot psoriasis
(copied with kind permission of Dermatoweb)
|
 |
Figure 37 – Hyperkeratotic foot psoriasis
|
Specific sites – nails
Psoriatic nail dystrophy mainly occurs in patients whom also suffer from psoriasis of the skin. Less than 5% of patients have solely psoriasis of the nails. It commonly affects patients with psoriatic arthropathy
Clinical findings
- Pitting
- Oil drop - translucent yellow-red discoloration in the nail
- Subungual hyperkeratosis – thickening of the nail bed, may lead to onycholysis
- Onycholysis – the nail plate separates from the nail bed. The nail plate becomes white / yellow
- Beau's lines – white transverse lines
- Leuconychia – areas of white nail plate
- Nail plate crumbling
Management
- If there is any diagnostic uncertainty samples must be sent for mycology to rule out tinea. It is important to not only include nail clippings but also scrapings from the undersurface of the nail plate, otherwise many cases of tinea will be missed. It must be remembered that psoriasis and tinea of the nails can co-exist
- Treatment of nails is difficult and results are often disappointing:
- Distal involvement - try and cut back the nail if possible then use Dovobet ointment ® or topical steroids
- More substantial involvement (including proximal nail) - consider referral to dermatology for a trial of triamcinolone injections via Dermojet. Systemic agents such as Methotrexate are occasionally used but benefit is not guarenteed, and the risk to benefit ratio means that such treatments are rarely justified unless the patient also has moderate-severe psoriasis of the skin
 |
Figure 38 – Psoriasis of the nails with pitting
(copied with kind permission of Dermatoweb)
|
 |
Figure 39 – Psoriasis with onycholysis
(copied with kind permission of Dermatoweb)
|
 |
Figure 40 – Psoriasis with onycholysis and Beau’s lines
|
Specific sites - flexures and genitalia
History
- It is always important to ask if patients have genital involvement as they may not otherwise come forward with the information. Genital involvement can be very uncomfortable and can interfere with relationships
Clinical findings
- Several sites can be affected including the axillae, under the breasts, umbilicus, groins, gluteal / natal (between buttocks) cleft, around the anus, penis / scrtoum and the vulva
- Morhology – lesions in the flexures are usually symmetrical, very shiny, red and well-demarcated. If affected areas are asymmetrical and scale is present always consider tinea and send scrapings for mycology
Treatment
- Moisturisers
- Topical steroids - the skin on flexural sites and the genitalia is relatively thin and so mild topical steroids such as Eumovate ® cream are preferred options. In cases of co-existent yeast a combination product such as Trimovate ® cream should be used. Stronger topical steroids need to be used with care and only for a few days at any one time. Treatment with topical steroids should be discontinued once symptoms settle
- The overuse of topical steroids in body folds may cause striae and can result in long-term aggravation of psoriasis (tachyphylaxis)
- If there are concerns that too much topical steroid is being used it can be worth trying a vitamin-D compound such as Curatoderm ® lotion / ointment or Silkis ® ointment, the other vitamin-D compounds can cause irritation on thin skin. Another option are the calcineurin inhibitors Elidel ® cream and Protopic ® ointment (both off-label in psoriasis)
- The skin on the gluteal cleft is thicker than on the other sites and so stronger treatments can be used if needed
 |
Figure 41 - Flexural psoriasis
Symmetrical, erythematous and shiny
|
 |
Figure 42 – Psoriasis of the penis and scrotum
|
 |
Figure 43 – Psoriasis of the vulva and groins
|
Psoriasis in children
Although the most common presentation of psoriasis in children is that of chronic plaque psoriasis, the diagnosis can be difficult and the following are more common findings in children compared with adults:
- Face, especially eyes and ears
- Scalp - may be the only presenting feature
- Guttate - some patients get one or two outbreaks and do not go on to develop psoriasis in adult life. In others the psoriasis persists
- Distal limbs
- 'Nappy rash' / genital involvement - it may that some infants diagnosed as having seborrhoeic dermatitis of the nappy area may instead have psoriasis
- An eczematised form of psoriasis - the two problems may co-exist
- One digit - often associated with paronychia and nail changes. Often recalcitrant to treatment, but many improve with time
- Chronic plaque psoriasis tends to be paler with less scale but is still well demarcated
Management - many of the same treatments used in adults are used in children
Prognosis - is difficult to predict, although just because a child has bad psoriasis does not mean that they will continue to have psoriasis as an adult. Patients with psoriatic arthropathy tend to have a worse prognosis
|